You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Low dose of IL-2

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Allergic Rhinoconjunctivitis to Birch Pollen, With a Positive Skin Prick Test to Birch Pollen Trial in Paris (ILT-101 ld-(IL2))

Completed
  • Allergic Rhinoconjunctivitis to Birch Pollen
  • With a Positive Skin Prick Test to Birch Pollen
  • ILT-101 ld-(IL2)
  • Paris, France
    CIC Paris Est GH Pitié Salpétrière
Dec 13, 2022

Alzheimer Trial in Houston (Aldesleukin)

Completed
  • Alzheimer Disease
  • Houston, Texas
    Alireza Faridar
Apr 19, 2023

Sjögren's Syndrome Trial in Beijing (low-dose interleukin-2, rapamycin)

Recruiting
  • Sjögren's Syndrome
  • Beijing, Beijing, China
    Peking university people's hospital
Dec 2, 2022

Alzheimer Trial in Paris (Proleukin, Placebo)

Not yet recruiting
  • Alzheimer Disease
  • Paris, France
    GHU Saint Anne
Jul 18, 2022

Systemic Lupus Erythematosus, Lupus Nephritis Trial in Nanjing (Human umbilical cord mesenchymal stem cells, Interleukin-2)

Recruiting
  • Systemic Lupus Erythematosus
  • Lupus Nephritis
  • Nanjing, Jiangsu, China
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University
Nov 20, 2022

Pleural Mesothelioma Trial in Toronto (Cyclophosphamide, Fludarabine, Autologous tumor infiltrating lymphocytes (TILs))

Completed
  • Pleural Mesothelioma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jan 8, 2023

Systemic Lupus Erythematosus Trial in Beijing (Telitacicept, Interleukin-2)

Recruiting
  • Systemic Lupus Erythematosus
  • Beijing, Beijing, China
    Department of Rheumatology and Immunology, Peking University Peo
Apr 26, 2022

GVHD Trial in Hackensack (Cyclophosphamide and Sirolimus, Low dose IL-2 with Cytoxan + Sirolimus, Low dose IL-2, low dose

Terminated
Has Results
  • Graft Versus Host Disease
  • Cyclophosphamide and Sirolimus
  • +3 more
  • Hackensack, New Jersey
    John Theurer Cancer Center at Hackensack University Medical Cent
Feb 4, 2022

Systemic Lupus Erythematosus Trial in Beijing (Belimumab, Interleukin-2)

Recruiting
  • Systemic Lupus Erythematosus
  • Beijing, China
    Department of Rheumatology and Immunology, Peking University Peo
Mar 24, 2022

Healthy Volunteers Trial in Paris (ILT101, Placebo)

Completed
  • Healthy Volunteers
  • Paris, France
    Clinical Investigation Center Paris Est Hôpital Universitaire Pi
Dec 10, 2021

Chronic GVHD Trial in Duarte (biological, procedure, other)

Active, not recruiting
  • Chronic Graft Versus Host Disease
  • Aldesleukin
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Multiple Myeloma Trial in Boston (CIML NK Cells plus KP1237 and low dose IL-2)

Recruiting
  • Multiple Myeloma
  • CIML NK Cells plus KP1237 and low dose IL-2
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 18, 2022

Bipolar Depression Trial in Créteil (ILT101, Placebos)

Recruiting
  • Bipolar Depression
  • Créteil, Hôpital Albert Chenevier, France
    Pr Marion Leboyer
Dec 10, 2021

Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Atlanta (Aldesleukin,

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • +3 more
  • Aldesleukin
  • Pembrolizumab
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Aug 8, 2022

TIA, Carotid Artery Plaque, Carotid Atherosclerosis Trial in Cambridge (Interleukin-2 [IL-2], Standard care - Carotid

Not yet recruiting
  • TIA
  • +2 more
  • Interleukin-2 [IL-2]
  • Standard care - Carotid Endarterectomy
  • Cambridge, Cambridgeshire, United Kingdom
    Addenbrookes Hospital
Aug 2, 2023

Amyotrophic Lateral Sclerosis Trial in Beijing (IL-2)

Recruiting
  • Amyotrophic Lateral Sclerosis
  • Beijing, Beijing, China
    Peking University Third Hospital
Aug 11, 2021

Type 1 Diabetes Trial (Cyclosporin, ILT101, Placebo)

Not yet recruiting
  • Type 1 Diabetes
  • (no location specified)
Dec 9, 2021

HNSCC, Melanoma, Gynecologic Cancer Trial in Portland (DP CD8 TIL, DP CD8 TIL KD, Low dose IL-2)

Recruiting
  • HNSCC
  • +5 more
  • DP CD8 TIL
  • +2 more
  • Portland, Oregon
    Providence Portland Medical Center
Jun 5, 2023

Ulcerative Colitis Trial in Boston (Interleukin-2 (aldesleukin).)

Completed
Has Results
  • Ulcerative Colitis
  • Interleukin-2 (aldesleukin).
  • Boston, Massachusetts
  • +1 more
Aug 3, 2021

Pancreatic Cancer, Surgery, Metastasis Trial (Histamine DiHCl (HDC), Interleukin-2 (IL-2))

Not yet recruiting
  • Pancreatic Cancer
  • +3 more
  • Histamine Dihydrochloride (HDC)
  • Interleukin-2 (IL-2)
  • (no location specified)
Mar 31, 2023

Metastatic Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7 Trial in Houston (biological,

Completed
  • Metastatic Melanoma
  • +3 more
  • Aldesleukin
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 27, 2022

Leiomyosarcoma Trial in Bad Saarow, Berlin (Dinutuximab Beta, Zoledronic acid, Interleukin-2)

Recruiting
  • Leiomyosarcoma
  • Dinutuximab Beta, Zoledronic acid, Interleukin-2
  • Bad Saarow, Germany
  • +1 more
Jun 2, 2022

Advanced Melanoma Trial in Basel (Combination of TIL Transfer with anti-PD-1 Therapy and low dose IL-2)

Recruiting
  • Advanced Melanoma
  • Combination of TIL Transfer with anti-PD-1 Therapy and low dose IL-2
  • Basel, Switzerland
    Division of Medical Oncology and Cancer Immunology, University H
Aug 3, 2021

Acute Coronary Syndromes Trial in Cambridge (Interleukin-2 [IL-2], Placebo Dextrose 5% solution)

Recruiting
  • Acute Coronary Syndromes
  • Interleukin-2 [IL-2]
  • Placebo Dextrose 5% solution
  • Cambridge, Cambridgeshire, United Kingdom
    Addenbrooke's Hospital
May 31, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (IOV-2001, Low dose IL-2, High dose IL-2)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • IOV-2001
  • +3 more
  • Tampa, Florida
  • +5 more
Jan 31, 2022